SQZ Biotechnologies Profit Margin 2020-2022 | SQZ
Current and historical gross margin, operating margin and net profit margin for SQZ Biotechnologies (SQZ) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. SQZ Biotechnologies net profit margin as of December 31, 2022 is -369.96%.
| SQZ Biotechnologies Annual Profit Margins |
| SQZ Biotechnologies Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.018B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
